Related Experiment Video
Updated: Jun 23, 2025
05:43
An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
Published on: November 8, 2024
307
Platelet Activation Pathways Controlling Reversible Integrin αIIbβ3 Activation.
Jinmi Zou1,2, Siyu Sun1,2, Ilaria De Simone1
1Platelet (patho)physiology, Synapse Research Institute, Maastricht, The Netherlands.
Summary
Protein kinase C (PKC) and autocrine adenosine diphosphate (ADP) signaling stabilize platelet aggregation by maintaining integrin αIIbβ3 activation. Inhibiting these pathways can reverse this activation, offering insights for antiplatelet therapies.
Area of Science:
- Hematology
- Molecular Biology
- Pharmacology
Background:
- Agonist-induced platelet activation involves integrin αIIbβ3 conformational change, crucial for fibrinogen binding and aggregation.
- The signaling pathways determining permanent versus transient platelet activation states remain incompletely understood.
- Understanding these pathways is key to elucidating reversible platelet aggregation phases.
Purpose of the Study:
- To investigate platelet signaling mechanisms regulated by glycoprotein VI (GPVI) and protease-activated receptors (PAR) for thrombin.
- To explore how these receptors influence time-dependent integrin αIIbβ3 activation.
- To identify signaling pathways controlling the reversibility of platelet activation.
Main Methods:
- Platelets were activated using collagen-related peptide (CRP) for GPVI, and thrombin receptor-activating peptides or thrombin for PAR1/PAR4.
- Integrin αIIbβ3 activation and P-selectin expression were measured via flow cytometry.
- Signaling pathway inhibitors were applied pre- and post-agonist stimulation; platelet spreading was assessed using microscopy.
Main Results:
- Inhibitor pretreatment revealed a hierarchy of protein kinase C (PKC) > glycogen synthase kinase 3 > β-arrestin > phosphatidylinositol-3-kinase in reducing GPVI/PAR-induced activation.
- Posttreatment showed secondary αIIbβ3 inactivation (but not P-selectin expression) for CRP and PAR1 agonists, following the same inhibitor order.
- Combined PKC inhibition, P2Y12 receptor blockade with ticagrelor, and PAR1/GPVI stimulation enhanced αIIbβ3 inactivation and altered platelet morphology.
Conclusions:
- PKC and autocrine ADP signaling are critical for sustained integrin αIIbβ3 activation, particularly after PAR1/GPVI stimulation.
- These pathways contribute to stabilized platelet aggregation, with implications for antiplatelet drug efficacy.
- Targeting PKC and P2Y12 pathways offers potential for modulating platelet activation reversibility.
Related Concept Videos
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
01:22Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
01:15Activation of Integrins
3.4K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.4K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.1K
01:10Integrins
3.9K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
3.9K
01:16Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K